& Xie, J

Contact your GP or healthcare provider if you experience : Unexpected vaginal bleeding or significant changes in menstrual patterns, particularly postmenopausal bleeding, which always requires investigation Suspected pregnancy or missed periods if sexually active, as Mounjaro should be discontinued during pregnancy Menopausal symptoms such as troublesome hot flushes, night sweats, or mood changes that affect quality of life Signs of contraceptive failure , including pregnancy symptoms, if relying on oral contraceptives without additional protection Persistent gastrointestinal symptoms (nausea, vomiting, diarrhoea) that might affect absorption of other medications, including contraceptives Right upper abdominal pain, fever or jaundice , which could indicate gallbladder disease (a risk associated with rapid weight loss and GLP-1 receptor agonists) Thyroid-related symptoms such as a neck lump, difficulty swallowing, or persistent hoarseness Seek urgent medical attention for symptoms suggesting serious complications, though these are rare: Severe abdominal pain, which could indicate pancreatitis (a known but uncommon adverse effect of GLP-1 receptor agonists) Signs of severe dehydration from gastrointestinal side effects Regular monitoring through your prescribing clinician should include assessment of treatment response, tolerability, and any concerns about hormonal or reproductive health

All products are for in-vitro use only and not intended for human or veterinary consumption
The Pharmacokinetics Behind the Switch Timing The 1 to 2 week washout recommendation is not arbitrary
Ongoing support Regular monitoring and follow-ups for safe, sustainable progress
Who Has Higher Hypoglycemia Risk